newsfilter
← Latest News
GlobeNewswire·

Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index

NEW YORK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel,